News + Font Resize -

AstraZeneca Pharma India Board recommends 35% dividend for FY-02
Our Bureau, Mumbai | Friday, February 28, 2003, 08:00 Hrs  [IST]

AstraZeneca Pharma India Ltd has informed BSE that the Board of Directors at its meeting held has decided to transfer Rs 100 million to General Reserve and recommended declaration of dividend @ 35% subject to the approval of the Shareholders at the Annual General Meeting.

Further, the Board accepted the resignation of R M Henry, Director, effective from the close of January 31, 2003.

Post Your Comment

 

Enquiry Form